FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969894047> ?p ?o ?g. }

• W2969894047 endingPage "96" @default.
• W2969894047 startingPage "80" @default.
• W2969894047 abstract "Previous study has suggested that the FABP5-PPARγ-signalling transduction pathway gradually replaces the androgen receptor activated pathway in promoting malignant progression of castration-resistant prostate cancer (CRPC) cells. To interfere with this newly discovered FABP5-related signalling pathway, we have produced a highly efficient recombinant FABP5 inhibitor, named dmrFABP5. Treatment with dmrFABP5 significantly supressed the proliferation, migration, invasion and colony formation of the highly malignant prostate cancer cells PC3-M in vitro. To test dmrFABP5's suppressive effect in CRPC, the human PC3-M cells were implanted orthotopically into the prostate gland of immunosuppressed mice to produce tumours. These mice were then treated with dmrFABP5 and produced a highly significant reduction of 100% in metastatic rate and a highly significant reduction of 13-fold in the average size of primary tumours. Immunocytochemial staining showed that the staining intensity of dmrFABP5 treated tumours was reduced by 67%. When tested in vitro, dmrFABP5 suppressed the cancer cells by blocking fatty acid stimulation of PPARγ, and thereby prevented it activating down-stream cancer-promoting or inhibiting cancer-suppressing genes. Our results show that the FABP5 inhibitor dmrFABP5 is a novel molecule for treatment of experimental CRPC and its inhibitory effect is much greater than that produced by SB-FI-26 reported in our previous work." @default.
• W2969894047 created "2019-08-29" @default.
• W2969894047 creator A5004557270 @default.
• W2969894047 creator A5006323887 @default.
• W2969894047 creator A5030863883 @default.
• W2969894047 creator A5032644364 @default.
• W2969894047 creator A5034988473 @default.
• W2969894047 creator A5046673252 @default.
• W2969894047 creator A5052559364 @default.
• W2969894047 creator A5056007719 @default.
• W2969894047 creator A5059266417 @default.
• W2969894047 creator A5065876451 @default.
• W2969894047 creator A5082429124 @default.
• W2969894047 creator A5083706661 @default.
• W2969894047 date "2019-05-24" @default.
• W2969894047 modified "2023-10-17" @default.
• W2969894047 title "Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ" @default.
• W2969894047 cites W1484870202 @default.
• W2969894047 cites W1544934333 @default.
• W2969894047 cites W1969725278 @default.
• W2969894047 cites W1982942933 @default.
• W2969894047 cites W1987120082 @default.
• W2969894047 cites W2008042903 @default.
• W2969894047 cites W2011455390 @default.
• W2969894047 cites W2026138332 @default.
• W2969894047 cites W2032911095 @default.
• W2969894047 cites W2035397440 @default.
• W2969894047 cites W2048261640 @default.
• W2969894047 cites W2066699861 @default.
• W2969894047 cites W2089567904 @default.
• W2969894047 cites W2097196562 @default.
• W2969894047 cites W2104656322 @default.
• W2969894047 cites W2108328105 @default.
• W2969894047 cites W2136423761 @default.
• W2969894047 cites W2137330819 @default.
• W2969894047 cites W2140675573 @default.
• W2969894047 cites W2159810380 @default.
• W2969894047 cites W2172674054 @default.
• W2969894047 cites W2284196610 @default.
• W2969894047 cites W2471044485 @default.
• W2969894047 cites W2622445425 @default.
• W2969894047 cites W4235160748 @default.
• W2969894047 doi "https://doi.org/10.18632/genesandcancer.192" @default.
• W2969894047 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6584209" @default.
• W2969894047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31258834" @default.
• W2969894047 hasPublicationYear "2019" @default.
• W2969894047 type Work @default.
• W2969894047 sameAs 2969894047 @default.
• W2969894047 citedByCount "19" @default.
• W2969894047 countsByYear W29698940472019 @default.
• W2969894047 countsByYear W29698940472020 @default.
• W2969894047 countsByYear W29698940472021 @default.
• W2969894047 countsByYear W29698940472022 @default.
• W2969894047 countsByYear W29698940472023 @default.
• W2969894047 crossrefType "journal-article" @default.
• W2969894047 hasAuthorship W2969894047A5004557270 @default.
• W2969894047 hasAuthorship W2969894047A5006323887 @default.
• W2969894047 hasAuthorship W2969894047A5030863883 @default.
• W2969894047 hasAuthorship W2969894047A5032644364 @default.
• W2969894047 hasAuthorship W2969894047A5034988473 @default.
• W2969894047 hasAuthorship W2969894047A5046673252 @default.
• W2969894047 hasAuthorship W2969894047A5052559364 @default.
• W2969894047 hasAuthorship W2969894047A5056007719 @default.
• W2969894047 hasAuthorship W2969894047A5059266417 @default.
• W2969894047 hasAuthorship W2969894047A5065876451 @default.
• W2969894047 hasAuthorship W2969894047A5082429124 @default.
• W2969894047 hasAuthorship W2969894047A5083706661 @default.
• W2969894047 hasBestOaLocation W29698940471 @default.
• W2969894047 hasConcept C104317684 @default.
• W2969894047 hasConcept C121608353 @default.
• W2969894047 hasConcept C126322002 @default.
• W2969894047 hasConcept C170493617 @default.
• W2969894047 hasConcept C185592680 @default.
• W2969894047 hasConcept C2776235491 @default.
• W2969894047 hasConcept C2780192828 @default.
• W2969894047 hasConcept C502942594 @default.
• W2969894047 hasConcept C543025807 @default.
• W2969894047 hasConcept C55493867 @default.
• W2969894047 hasConcept C63932345 @default.
• W2969894047 hasConcept C71924100 @default.
• W2969894047 hasConcept C86339819 @default.
• W2969894047 hasConceptScore W2969894047C104317684 @default.
• W2969894047 hasConceptScore W2969894047C121608353 @default.
• W2969894047 hasConceptScore W2969894047C126322002 @default.
• W2969894047 hasConceptScore W2969894047C170493617 @default.
• W2969894047 hasConceptScore W2969894047C185592680 @default.
• W2969894047 hasConceptScore W2969894047C2776235491 @default.
• W2969894047 hasConceptScore W2969894047C2780192828 @default.
• W2969894047 hasConceptScore W2969894047C502942594 @default.
• W2969894047 hasConceptScore W2969894047C543025807 @default.
• W2969894047 hasConceptScore W2969894047C55493867 @default.
• W2969894047 hasConceptScore W2969894047C63932345 @default.
• W2969894047 hasConceptScore W2969894047C71924100 @default.
• W2969894047 hasConceptScore W2969894047C86339819 @default.
• W2969894047 hasIssue "3-4" @default.
• W2969894047 hasLocation W29698940471 @default.
• W2969894047 hasLocation W29698940472 @default.
• W2969894047 hasLocation W29698940473 @default.

• next